455
Views
10
CrossRef citations to date
0
Altmetric
Review Article

“Maternal diabetes mellitus and its impact on the risk of delivering a child with congenital heart disease: a systematic review and meta-analysis”

ORCID Icon, , , , , , , , , , & show all
Pages 7685-7694 | Received 31 Mar 2021, Accepted 23 Jul 2021, Published online: 06 Aug 2021

References

  • WHO. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:67–74.
  • Gavin JR, Alberti KGMM, Davidson MB, et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2002;25:1183–1197.
  • Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8(12):489–511.
  • Wagner S, Chen H-Y, Ocon AL, et al. Association between time of delivery and composite adverse outcomes in pregnancies complicated by diabetes. J Matern Neonatal Med. 2021;1–7.
  • Vinceti M, Malagoli C, Rothman KJ, et al. Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol. 2014;29(6):411–418.
  • Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetes mellitus and infant malformations. Am Coll Obstet Gynecol. 2002;100:925–930.
  • Bánhidy F, Ács N, Puhó EH, et al. Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: a population-based case-control study. Congenit Anom. 2010;50(2):115–121.
  • Van Der Linde D, Konings EEM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–2247.
  • Macintosh MCM, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333(7560):177–180.
  • Clausen TD, Mathiesen E, Ekbom P, et al. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care. 2005;28(2):323–328.
  • Agha MM, Glazier RH, Moineddin R, et al. Congenital abnormalities in newborns of women with pregestational diabetes: a time-trend analysis, 1994 to 2009. Birth Defects Res A Clin Mol Teratol. 2016;106(10):831–839.
  • Landis BJ, Levey A, Levasseur SM, et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr Cardiol. 2013;34(3):597–605.
  • Lisowski LA, Verheijen PM, Copel JA, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz. 2010;35(1):19–26.
  • Balsells M, García-Patterson A, Gich I, et al. Major congenital malformations in women with gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2014;32:13–23.
  • Simeone RM, Devine OJ, Marcinkevage JA, et al. Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am J Prev Med. 2015;48(2):195–204.
  • Peticca P, Keely EJ, Walker MC, et al. Pregnancy outcomes in diabetes subtypes: how do they compare? A province-based study of Ontario, 2005–2006. J Obstet Gynaecol Canada. 2009;31(6):487–496.
  • Moher D, PRISMA-P Group, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
  • Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197.
  • WHO. Diabetes mellitus : report of a WHO study group [meeting held in Geneva from 11 to 16 February 1985]. World Health Organization; 1985. p. jap published by: Tokyo : Japan Public Health Association.
  • Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart. 2003;89(10):1217–1220.
  • Eidem I, Stene LC, Henriksen T, et al. Congenital anomalies in newborns of women with type 1 diabetes: Nationwide population-based study in Norway, 1999–2004. Acta Obstet Gynecol Scand. 2010;89(11):1403–1411.
  • Bell R, Glinianaia SV, Tennant PWG, et al. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55(4):936–947.
  • Øyen N, Diaz LJ, Leirgul E, et al. Prepregnancy diabetes and offspring risk of congenital heart disease: a nationwide cohort study. Circulation. 2016;133(23):2243–2253.
  • Leirgul E, Brodwall K, Greve G, et al. Maternal diabetes, birth weight, and neonatal risk of congenital heart defects in Norway, 1994–2009. Obstet Gynecol. 2016;128(5):1116–1125.
  • Lo CKL, Mertz D, Loeb M. Newcastle–Ottawa scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14(1):1–5.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation. 2013;128(6):583–589.
  • Brite J, Laughon SK, Troendle J, et al. Maternal overweight and obesity and risk of congenital heart defects in offspring. Int J Obes. 2014;38(6):878–882.
  • Liu X, Liu G, Wang P, et al. Prevalence of congenital heart disease and its related risk indicators among 90,796 Chinese infants aged less than 6 months in Tianjin. Int J Epidemiol. 2015;44(3):884–893.
  • Hoang TT, Marengo LK, Mitchell LE, et al. Original findings and updated meta-analysis for the association between maternal diabetes and risk for congenital heart disease phenotypes. Am J Epidemiol. 2017;186(1):118–128.
  • Borelli M, Baer RJ, Chambers CD, et al. Critical congenital heart defects and abnormal levels of routinely collected first- and second-trimester biomarkers. Am J Med Genet. 2017;173(2):368–374.
  • Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60(4):636–644.
  • Ludvigsson JF, Neovius M, Söderling J, et al. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden. BMJ. 2018;362:1–9.
  • Reddi Rani P, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagnostic Res. 2016;10:QE01–QE04.
  • Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
  • Committee opinion no. 504: Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol. 2011;118:751–753.
  • Engelgau MM, Herman WH, Smith PJ, et al. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care. 1995;18(7):1029–1033.
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868.
  • Buchanan TA, Xiang AH. Science in medicine gestational diabetes mellitus. Diabetes. 2005;115:485–491.
  • Burlina S, Dalfrà MG, Lapolla A. Long-term cardio- metabolic effects after gestational diabetes: a review. J Matern Neonatal Med. 2021;1–8.
  • Coustan DR, Carpenter MW, O'Sullivan PS, et al. Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol. 1993;168(4):1139–1144.
  • EUROCAT. Congenital defects in Europe: cases and prevalence for all full member registries from 2012 to 2017. Available from: http://www.eurocat-network.eu/AccessPrevalenceData/PrevalenceTables. 2019.
  • Ailes EC, Gilboa SM, Honein MA, et al. Estimated number of infants detected and missed by critical congenital heart defect screening. Pediatrics. 2015;135(6):1000–1008.
  • Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, et al. The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:11.
  • Hillier TA, Pedula KL, Ogasawara KK, et al. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med. 2021;384(10):895–904.
  • Satodiya M, Takkar N, Goel P, et al. Comparison of one-step versus two-step screening for diagnosis of GDM in Indian population: a randomized controlled trial. J Obstet Gynaecol India. 2017;67(3):190–195.
  • Williams K, Carson J, Lo C. Genetics of congenital heart disease. Biomolecules. 2019;9(12):879.
  • Van Der Bom T, Zomer AC, Zwinderman AH, et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50–60.
  • Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199(3):237.e1–237.e9.
  • Reece EA. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep. 2012;12(1):24–32.
  • Ray JG, O’Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Obstet Gynecol Surv. 2002;57:71–72.
  • Zhang Y, Xia M, Weng S, et al. Effect of Mediterranean diet for pregnant women: a meta-analysis of randomized controlled trials. J Matern Neonatal Med. 2021;1–11.
  • Sweeting AN, Hsieh A, Wong J, et al. Comparison  of a subcutaneous versus intravenous insulin protocol for managing hyperglycemia following antenatal betamethasone in women with diabetes: a pilot randomized controlled trial. J Matern Neonatal Med. 2021;1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.